← Evidence map

ReviewJournal of diabetes science and technology2023

The First Interchangeable Biosimilar Insulin: Insulin Glargine-yfgn.

Mark C Matli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34971335